2022-06-03
Researchers have developed a multifunctional nanoplatform based on mesoporous hexagonal core-shell zinc porphyrin-silica nanoparticles (MPSNs) loaded with R837, which can be used to integrate PDT, PTT, and tumor-specific immunotherapy for breast cancer.
